SGMO stock rated a Sector perform by RBC Capital Mkts

ZOM Stock

Sangamo Therapeutics Inc’s filing revealed that its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 per share,6,000,000 shares were sold. As a result of this transaction, BIOGEN INC. now holds 17,652,466 shares worth roughly $11.3 million. RBC Capital Mkts downgraded its Sangamo […]

RBC Capital Mkts downgrades Sangamo Therapeutics Inc (SGMO) rating to a Sector perform

CHWY Stock

Sangamo Therapeutics Inc’s recently made public that its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 per share,6,000,000 shares were sold. As a result of this transaction, BIOGEN INC. now holds 17,652,466 shares worth roughly $15.0 million. RBC Capital Mkts downgraded its […]

Short interest on SGMO sees a significant increase on Feb 29, 2024

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sangamo Therapeutics Inc shares valued at $3,000,000 were sold by BIOGEN INC. on Sep 26 ’23. At $0.50 per share, BIOGEN INC. sold 6,000,000 shares. The insider’s holdings dropped to 17,652,466 shares worth approximately $13.77 million following […]

Sangamo Therapeutics Inc [SGMO] Investment Appeal on the Rise

Sangamo Therapeutics Inc’s filing revealed that its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 per share,6,000,000 shares were sold. As a result of this transaction, BIOGEN INC. now holds 17,652,466 shares worth roughly $15.53 million. RBC Capital Mkts downgraded its Sangamo […]

SGMO’s short interest surges to 9.73 million shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Sangamo Therapeutics Inc shares valued at $3,000,000 were sold by BIOGEN INC. on Sep 26 ’23. At $0.50 per share, BIOGEN INC. sold 6,000,000 shares. The insider’s holdings dropped to 17,652,466 shares worth approximately […]

SGMO’s latest rating updates from top analysts.

Sangamo Therapeutics Inc’s recently made public that its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26. In the deal valued at $0.50 per share,6,000,000 shares were sold. As a result of this transaction, BIOGEN INC. now holds 17,652,466 shares worth roughly $18.01 million. RBC Capital Mkts downgraded its Sangamo […]

Sharp increase in SGMO’s short interest leads to surge in days-to-cover ratio

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sangamo Therapeutics Inc shares valued at $3,000,000 were sold by BIOGEN INC. on Sep 26. At $0.50 per share, BIOGEN INC. sold 6,000,000 shares. The insider’s holdings dropped to 17,652,466 shares worth approximately $20.48 million following the […]

Keeping an Eye on Sangamo Therapeutics Inc (SGMO) After Insider Trading Activity

In a filing, Sangamo Therapeutics Inc revealed its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26. In the deal valued at $0.50 per share,6,000,000 shares were sold. As a result of this transaction, BIOGEN INC. now holds 17,652,466 shares worth roughly $19.77 million. RBC Capital Mkts downgraded its Sangamo […]

SGMO short interest jump by 8.42%, reflecting negative sentiment

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sangamo Therapeutics Inc shares valued at $3,000,000 were sold by BIOGEN INC. on Sep 26. At $0.50 per share, BIOGEN INC. sold 6,000,000 shares. The insider’s holdings dropped to 17,652,466 shares worth approximately $19.42 million following the […]